Evidence map›Paper›PMID 17053897›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2006

Propiverine and metabolites: differences in binding to muscarinic receptors and in functional models of detrusor contraction.

Melinda Wuest, Anke Weiss, Magali Waelbroeck, Manfred Braeter, Lutz-Ullrich Kelly, Oliver W Hakenberg, Ursula Ravens

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 43 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. [Drug-drug interactions in urology].Der Urologe. Ausg. A · 2009
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Electrophysiological profile of propiverine--relationship to cardiac risk.Naunyn-Schmiedeberg's archives of pharmacology · 2008
    Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Melinda WuestMedizinische Fakultät, Institut für Pharmakologie und Toxikologie, TU Dresden, Fetscherstrasse 74, Dresden, Germany. melinda.wuest@tu-dresden.de
Anke Weiss
Magali Waelbroeck
Manfred Braeter
Lutz-Ullrich Kelly
Oliver W Hakenberg
Ursula Ravens
TU Dresden · DEApogepha Arzneimittel (Germany) · DEDiakonissenkrankenhaus · DEUniversité Libre de Bruxelles · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Propiverine is a commonly used antimuscarinic drug used as therapy for symptoms of an overactive bladder. Propiverine is extensively biotransformed into several metabolites that could contribute to its spasmolytic action. In fact, three propiverine metabolites (M-5, M-6 and M-14) have been shown to affect various detrusor functions, including contractile responses and L-type calcium-currents, in humans, pigs and mice, albeit with different potency. The aim of our study was to provide experimental evidence for the relationship between the binding of propiverine and its metabolites to human muscarinic receptor subtypes (hM(1)-hM(5)) expressed in chinese hamster ovary cells, and to examine the effects of these compounds on muscarinic receptor-mediated detrusor function. Propiverine, M-5, M-6 and M-14 bound to hM(1)-hM(5) receptors with the same order of affinity for all five subtypes: M-6 > propiverine > M-14 > M-5. In HEK-293 cells expressing hM(3), carbachol-induced release of intracellular Ca(2+) ([Ca(2+)](i)) was suppressed by propiverine and its metabolites; the respective concentration-response curves for carbachol-induced Ca(2+)-responses were shifted to the right. At higher concentrations, propiverine and M-14, but not M-5 and M-6, directly elevated [Ca(2+)](i). These results were confirmed for propiverine in human detrusor smooth muscle cells (hDSMC). Propiverine and the three metabolites decreased detrusor contractions evoked by electric field stimulation in a concentration-dependent manner, the order of potency being the same as the order of binding affinity. We conclude that, in comparison with the parent compound, loss of the aliphatic side chain in propiverine metabolites is associated with higher binding affinity to hM(1)-hM(5) receptors and higher functional potency. Change from a tertiary to a secondary amine (M-14) results in lower binding affinity and reduced potency. Oxidation of the nitrogen (M-5) further lowers binding affinity as well as functional potency.

Indexed as

AnimalsBenzilatesBinding, CompetitiveCalciumCarbacholCell LineCells, CulturedCHO CellsCholinergic AntagonistsCricetinaeCricetulusDose-Response Relationship, DrugElectric StimulationEpithelial CellsHumansMolecular Structure4-diphenylacetoxy-1,1-dimethylpiperidiniumBenzilatesCalciumCarbacholCholinergic AntagonistsN-MethylscopolamineParasympatholyticsPiperidinesPotassium ChloridepropiverineReceptors, Muscarinic

Identifiers

PMID17053897
OpenAlexW1988352349

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.